Everpharma Cerebrolysin — 215.2 mg/mL — 5 x10 mL Ampoules (10,760mg in total)

Cerebrolysin® is a complex peptide preparation manufactured by Ever Neuro Pharma GmbH (Unterach, Austria) through standardized enzymatic hydrolysis of porcine brain tissue, yielding a defined aqueous solution of low-molecular-weight neuropeptides, peptide fragments, and free amino acids at a standardized concentration of 215.2 mg/ml. Ever Pharma’s Cerebrolysin is the original branded preparation in this complex peptide class and has been the subject of extensive academic and clinical research literature for over five decades (Windisch, Hartbauer, Sugita, and colleagues). The preparation has been investigated in preclinical and clinical research literature for neurotrophic-like activity, CNTF-domain and IGF-1-domain peptide fragment pharmacology, BDNF gene expression endpoints, and mitochondrial function research in neuronal cell models. Cerebrolysin is supplied here in its original Ever Pharma manufacturer packaging as an aqueous solution presentation (no reconstitution required), with 10 amber glass ampoules of 10 ml per ampoule (215.2 mg/ml concentration; 2152 mg per ampoule; 21,520 mg total per package). The compound has undergone clinical research investigation in Russia, Austria, China, and many other markets, though it remains an investigational research compound in US and Canadian markets without approved regulatory status.

Benefits (Research Focus)

• Complex brain peptide research — studied as the original Ever Pharma porcine brain peptide preparation for comparative pharmacology research

• BDNF pathway research — investigated for BDNF gene expression endpoints in neuronal cell research models

• CNTF-domain peptide research — explored for CNTF-domain peptide fragment activity (parent preparation from which derived analogs including P21 / P021 were identified)

• Mitochondrial function research — examined for cellular bioenergetics endpoints in neuronal cell research

• Comparative peptide complex research — researched alongside Cortexin (Geropharm calf brain peptide preparation) for comparative complex peptide preparation studies

What Researchers Look At

• BDNF gene and protein expression in neuronal cell research models

• Mitochondrial markers and cellular bioenergetics endpoints

• CNTF-domain peptide fragment pharmacology research

• Comparative pharmacology versus derived synthetic peptide analogs (P21 / P021)

• Comparative pharmacology versus Cortexin and other complex brain peptide preparations

Quick Specs

• Form: Sterile aqueous solution (no reconstitution required)

• Concentration: 215.2 mg/ml Cerebrolysin (standardized)

• Ampoule Volume: 10 ml per ampoule

• Cerebrolysin per Ampoule: 2,152 mg

• Quantity: 10 amber glass ampoules per package

• Total Cerebrolysin per Package: 21,520 mg (21.52 g)

• Manufacturing: Ever Neuro Pharma GmbH (Unterach, Austria)

• Composition: Mixed low-molecular-weight porcine brain peptides and amino acids (complex peptide solution, not single-sequence)

• Storage: Protect from light

Identity Basics

• Product: Cerebrolysin (porcine brain peptide hydrolysate solution)

• Synonyms: Cerebrolysinum; Cerebrolysin Ever Pharma; porcine brain peptide complex solution; CNTF-domain containing peptide preparation

• Class: Complex peptide preparation; not a single-sequence peptide; aqueous solution presentation

• Source: Enzymatic hydrolysis of porcine brain tissue under standardized Ever Pharma manufacturing process

• Composition: Mixed low-molecular-weight neuropeptides and free amino acids in aqueous solution

• Manufacturer: Ever Neuro Pharma GmbH (A-4866 Unterach, Austria)

• Package format: 10 amber glass ampoules × 10 ml per ampoule (215.2 mg/ml concentration)

• CAS: 12656-61-0 (Cerebrolysin peptide complex category)

⚠️ Disclaimer

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.
• Not for pediatric research applications outside controlled laboratory settings.

Manufacturer Verification Notice: This product is supplied in its original Ever Neuro Pharma-manufactured packaging with manufacturer-issued batch number and expiration date printed on each ampoule and on the outer carton. Verification of authenticity relies on Ever Pharma manufacturer documentation rather than third-party laboratory analysis (which is the standard for synthetic research peptides). Customers should verify package integrity, intact original packaging, intact ampoule glass, and visible batch/expiration markings upon receipt.

Manufacturer Documentation

• Manufacturer: Ever Neuro Pharma GmbH (A-4866 Unterach, Austria)

• Manufacturing Standard: EU GMP-compliant Austrian pharmaceutical manufacturing

• Concentration Standard: 215.2 mg/ml Cerebrolysin (Ever Pharma proprietary standardized preparation)

• Verification: Each ampoule and outer carton includes Ever Pharma-issued batch number and expiration date for manufacturer traceability

• Third-Party Testing Note: Independent third-party HPLC purity testing (such as Janoshik analysis) applies to single-sequence synthetic research peptides. Cerebrolysin is a complex peptide preparation supplied in its original Ever Pharma manufacturer packaging and is verified by manufacturer batch documentation rather than third-party single-peptide analysis.